Here you can find the latest news and updates from EUCAST.

22 Sep 2021
Susceptibility testing of anaerobic bacteria

EUCAST has developed a disk diffusion method for AST of five important anaerobic species (Bacteroides spp, Prevotella spp., Fusobacterium necrophorum, Clostridium perfringens and Cutibacterium acnes). Methodology, QC criteria and...[more]

20 Sep 2021
Disk diffusion methodology and QC of anaerobic bacteria

Three months ahead of releasing breakpoints and disk diffusion correlates EUCAST publishes the methodology, the QC criteria and a disk diffusion reading guide.[more]

23 Aug 2021
Review: vanco, teico, tela, dalba and oritavancin

Vancomycin, teicoplanin, telavancin, dalbavancin and oritavancin reviewed.[more]

18 Aug 2021
Review: Azithromycin, Telithromycin, Spiramycin, Tulathromycin

As part of the 2020-2021 general review and revision of MIC distributions and ECOFFs, these agents were now completed.[more]

27 Jul 2021
Review of MIC distributions of several agents

MIC distributions of several agents (trimethoprim-sulfamethoxazole, trimethoprim, rifampicin, erythromycin, clarithromycin) were reviewed as part of the 2021 full review of the entire MIC distribution database.[more]

09 Jul 2021
Brief information on EUCAST definitions of S, I and R to clinical colleagues.

An abbreviated information on the EUCAST 2019/20 changes to the definitions and use of S, I and R. Please distribute to clinical colleagues who are normally not up to date on susceptibility testing matters.[more]

01 Jul 2021
EUCAST calibration and validation graphs updated

Calibration and validation graphs related to breakpoint table v 11.0 (2021) updated 1 July, 2021.New for 2021, apart from introducing revised and new breakpoints for relevant agents and species,are graphs for...[more]

Displaying results 22 to 28 out of 50